1-5 of 5
William Townsend
Close
Sort by
Journal Articles

Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience

Clinical Trials & Observations
Rohan Shotton, Rachel Broadbent, Alia Alchawaf, Mohamed Bakri Mohamed, Adam Gibb, Nicolás Martinez-Calle, Christopher P. Fox, Mark Bishton, Alexandra Pender, Mary Gleeson, David Cunningham, Andrew Davies, Sina Yadollahi, Toby A. Eyre, Graham Collins, Faouzi Djebbari, Shireen Kassam, Paula Garland, Emily Watts, Wendy Osborne, William Townsend, Rachael Pocock, Matthew J. Ahearne, Fiona Miall, Xin Wang, Kim M. Linton
Journal: Blood Advances
Blood Adv (2024) 8 (4): 878–888.
https://doi.org/10.1182/bloodadvances.2023011305
Published: 2024
Includes: Supplemental data
Journal Articles

Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma

Claire Roddie, Lorna Neill, Wendy Osborne, Sunil Iyengar, Eleni Tholouli, David Irvine, Sridhar Chaganti, Caroline Besley, Adrian Bloor, Ceri Jones, Ben Uttenthal, Rod Johnson, Robin Sanderson, Kathleen Cheok, Maria Marzolini, William Townsend, Maeve O'Reilly, Amy A. Kirkwood, Andrea Kuhnl
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2872–2883.
https://doi.org/10.1182/bloodadvances.2022009019
Published: 2023
Includes: Supplemental data
Journal Articles

Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL

Clinical Trials & Observations
Michael Northend, William Wilson, Wendy Osborne, Christopher P. Fox, Andrew J. Davies, Dima El-Sharkawi, Elizabeth H. Phillips, Hau Wui Sim, Shalal Sadullah, Nimish Shah, Ying Ying Peng, Iman Qureshi, Juanah Addada, Rocio Figueroa Mora, Neil Phillips, Andrea Kuhnl, Elizabeth Davies, David Wrench, Pamela McKay, Indrani Karpha, Anna Cowley, Richard Karim, Sarah Challenor, Vikram Singh, Cathy Burton, Rebecca Auer, Chris Williams, Joel Cunningham, Angus Broom, Anita Arasaretnam, Claire Roddie, Tobias Menne, William Townsend
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2920–2926.
https://doi.org/10.1182/bloodadvances.2021005953
Published: 2022
Includes: Supplemental data
Journal Articles

Early FDG-PET response predicts CAR-T failure in large B-cell lymphoma

Clinical Trials & Observations
Andrea Kuhnl, Claire Roddie, Amy A. Kirkwood, Tobias Menne, Maria Cuadrado, Maria A. V. Marzolini, Wendy Osborne, Robin Sanderson, Maeve O’Reilly, William Townsend, Reuben Benjamin, Victoria Potter, Piers E. M. Patten, Deborah Yallop, Stefan Voo, George S. Petrides, Nicola Mulholland, Irfan Kayani
Journal: Blood Advances
Blood Adv (2022) 6 (1): 321–326.
https://doi.org/10.1182/bloodadvances.2021005807
Published: 2022
Journal Articles

Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial

Clinical Trials & Observations
Alex F. Herrera, Catherine Burton, John Radford, Fiona Miall, William Townsend, Armando Santoro, Pier Luigi Zinzani, David Lewis, Camilla Fowst, Satjit Brar, Bo Huang, Aron Thall, Graham P. Collins
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3387–3396.
https://doi.org/10.1182/bloodadvances.2021004511
Published: 2021
Includes: Supplemental data